Author:
Yang Shuai,Li Xudong,Yan Jinhong,Jiang Fangchao,Fan Xuehui,Jin Jing,Zhang Weihua,Zhong Di,Li Guozhong
Abstract
AbstractIn the current study, we aimed to investigate whether disulfiram (DSF) exerts a neuroprotective role in cerebral ischemiareperfusion
(CI-RI) injury by modulating ferredoxin 1 (FDX1) to regulate copper ion (Cu) levels and inhibiting inflammatory
responses. To simulate CI-RI, a transient middle cerebral artery occlusion (tMCAO) model in C57/BL6 mice was employed. Mice were administered with or without DSF before and after tMCAO. Changes in infarct volume after tMCAO were observed using TTC staining. Nissl staining and hematoxylin–eosin (he) staining were used to observe the morphological changes of nerve cells at the microscopic level. The inhibitory effect of DSF on initial inflammation was verified by TUNEL assay, apoptosis-related protein detection and iron concentration detection. FDX1 is the main regulatory protein of copper death, and the occurrence of copper death will lead to the increase of HSP70 stress and inflammatory response. Cuproptosis-related proteins and downstream inflammatory factors were detected by western blotting, immunofluorescence staining, and immunohistochemistry. The content of copper ions was detected using a specific kit, while electron microscopy was employed to examine mitochondrial changes. We found that DSF reduced the cerebral infarction volume, regulated the expression of cuproptosis-related proteins, and modulated copper content through down regulation of FDX1 expression. Moreover, DSF inhibited the HSP70/TLR-4/NLRP3 signaling pathway. Collectively, DSF could regulate Cu homeostasis by inhibiting FDX1, acting on the HSP70/TLR4/NLRP3 pathway to alleviate CI/RI. Accordingly, DSF could mitigate inflammatory responses and safeguard mitochondrial integrity, yielding novel therapeutic targets and mechanisms for the clinical management of ischemia–reperfusion injury.
Funder
Heilongjiang Province Key R&D Program
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Donnan, G. A., Fisher, M., Macleod, M. & Davis, S. M. Stroke. Lancet (Lond., Engl.) 371(9624), 1612–1623 (2008).
2. Huo, X. & Gaofeng,. Chinese guidelines for endovascular treatment of acute ischemic stroke 2023. Chin. J. Stroke 18(06), 684–711 (2023).
3. Jurcau, A. & Simion, A. Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: From pathophysiology to therapeutic strategies. IJMS 23, 14 (2021).
4. Chen, D., Guo, Y., Li, X., Zhang, G. & Li, P. Small molecules as modulators of regulated cell death against ischemia/reperfusion injury. Med. Res. Rev. 42, 2067–2101 (2022).
5. Galluzzi, L. et al. Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015. Cell Death Differ. 22, 58–73 (2015).